Type 1 Diabetes — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Ability to set variable basal rates and precise bolus dosing
Insulin pump therapy (continuous subcutaneous insulin infusion, CSII) allows programmable variable basal rates throughout the day and precise bolus dosing for meals and corrections. This provides more physiological insulin delivery than MDI. However, DKA risk may actually increase if pump failure is not promptly recognised, and blood glucose monitoring remains essential.
Reference: ISPAD – 2024 – Clinical Practice Consensus Guidelines: Insulin Pump Therapy